 CAMBRIDGE, Mass., Dec. 04, 2020 GLOBE NEWSWIRE -- Cerevel Therapeutics Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced it will host a live webcast providing a current corporate overview, followed by a moderated question and answer session on Monday, December 14. 